![Olivier Bogillot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Bogillot
Directeur/Membre du Conseil chez
CLARIANE SE
Fortune : 27 071 $ au 31/07/2026
Profil
Olivier Bogillot is currently Chairman at Sanofi Pasteur Merieux SAS since 2020.
Formerly, Dr. Bogillot was Chairman & Chief Executive Officer at Sanofi-Aventis France SA and President & Director at Provention Bio, Inc. Dr. Bogillot earned a doctorate from the University of Lyon.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLARIANE SE 0 % | 31/12/2025 | 5 897 ( 0 % ) | 27 071 $ | 31/07/2026 |
Postes actifs de Olivier Bogillot
| Sociétés | Poste | Début |
|---|---|---|
| CLARIANE SE | Directeur/Membre du Conseil | 14/05/2025 |
Sanofi Pasteur Merieux SAS
 Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Président | 01/03/2020 |
Anciens postes connus de Olivier Bogillot
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Directeur Général | - |
| PROVENTION BIO, INC. | President | - |
Formation de Olivier Bogillot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Clariane SE
 Clariane SE Medical/Nursing ServicesHealth Services Operates retirement homes | Health Services |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Finance |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
